[ad_1]
Trxade Health Inc (NASDAQ: MEDS ), a leading healthcare IT company, reported a double-digit increase in revenue for fiscal 2022. The company’s full-year net loss narrowed from the previous year.
Revenue increased 16% from last year to $11.45 million. As a result, Trxade Health’s attributable net loss narrowed to $3.47 million or $0.41 per share in fiscal 2022 from $5.32 million or $0.65 per share in the twelve months ended December 2021.
“I am pleased with the growth we have experienced on our Trxade platform. We continue to reach important milestones on our internal roadmap by focusing on innovation and development through various complementary growth opportunities,” said Trxade CEO Suren Ajjarapu.
Trxade shares have gained about 52% since the start of the year. Shares closed Monday’s session higher.
(this story will be updated soon)
[ad_2]
Source link